Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 3/2001

01-05-2001 | Short communication

The desire to be fashionable. Should we consider it a risk factor for infection in adolescents with acute leukaemia?

Authors: Elio Castagnola, Concetta Micalizzi, Carla Manzitti, Loredana Tasso

Published in: Supportive Care in Cancer | Issue 3/2001

Login to get access
Metadata
Title
The desire to be fashionable. Should we consider it a risk factor for infection in adolescents with acute leukaemia?
Authors
Elio Castagnola
Concetta Micalizzi
Carla Manzitti
Loredana Tasso
Publication date
01-05-2001
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2001
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200000200

Other articles of this Issue 3/2001

Supportive Care in Cancer 3/2001 Go to the issue

Short communication

Gabapentin for opioid-related myoclonus in cancer patients

Original Article

Follow-up of patients with haematological malignancies and their families in regional, rural and remote Queensland: the GPs' perspective

Original Article

The impact of pamidronate on inpatient and outpatient services among metastatic breast cancer patients

Original article

Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects

Editorial

Hydrate or dehydrate

Letter To The Editor

Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits